DENALI 501CEMENT

K141503 · Denali Corporation · EMA · Nov 10, 2014 · Dental

Device Facts

Record IDK141503
Device NameDENALI 501CEMENT
ApplicantDenali Corporation
Product CodeEMA · Dental
Decision DateNov 10, 2014
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3275
Device ClassClass 2
AttributesTherapeutic

Indications for Use

Denali 501 Cement is a resin-based cement recommended for the bonding of ceramic, metal and composite restorations. For Use only by a Licensed Dentist. Rx Use Only.

Device Story

Denali 501 Cement is a two-part, resin-based dental cement used by licensed dentists in clinical settings for bonding ceramic, metal, and composite restorations. The material contains polymerizable monomers that harden via light activation or through chemical setting upon mixing Part A and Part B. Once set, the resin exhibits low water solubility, providing long-term cementation. The device is applied by the dentist to secure dental restorations, directly impacting the structural integrity and retention of the prosthetic. It functions as a restorative material to benefit patients by ensuring durable attachment of dental work.

Clinical Evidence

No clinical data. Substantial equivalence is supported by bench testing comparing physical and mechanical properties (tensile/compressive strength, solubility, film thickness, depth of cure, setting time) against predicate devices.

Technological Characteristics

Two-part, resin-based dental cement containing polymerizable monomers. Features dual-cure capability (light-activated or chemical set). Properties include low water solubility, specific film thickness, and mechanical strength (tensile/compressive). Biocompatible formulation.

Indications for Use

Indicated for the bonding of ceramic, metal, and composite dental restorations. For use by licensed dentists only.

Regulatory Classification

Identification

Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.

Predicate Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an emblem featuring a stylized representation of three human profiles facing right, with flowing lines suggesting movement or connection. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 November 10,2014 Denali Corporation Jan G. Stannard President 134 Old Washington Street Hanover. MA 02339 Re: K141503 Trade/Device Name: Denali 501 Cement Regulation Number: 21 CFR 872.3275(b) Regulation Name: Dental Cement Regulatory Class: II Product Code: EMA Dated: August 7, 2014 Received: August 19, 2014 Dear Dr. Stannard: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Susan Runno DDS, mA Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for Denali Corporation. The logo consists of a blue triangle with a sphere and orbital ring on the left side. To the right of the logo is the text "denali corporation" in a dark gray sans-serif font. ## INDICATIONS FOR USE STATEMENT 510 (k) Number (if known) K141503 Device Name Denali 501 Cement ## Indications for Use: Denali 501 Cement is a two part, resin-based cement recommended for the bonding of ceramic, metal and composite restorations. For Use only by a Licensed Dentist. Rx Use Only. Please do not write below this line. Continue on another page if needed. Concurrence of CDRH, Office of Device Evaluation (ODE) 风 Prescription Use (Per 21 CFR 801.109) or Over-The-Counter Use {3}------------------------------------------------ ## 510 (k) Summary Image /page/3/Picture/1 description: The image shows the logo for Denali Corporation. The logo includes a blue and black geometric shape with a blue sphere and a gray orbit around it. The text "denali corporation" is written in gray next to the logo, and the address "134 Old Washington Street, Hanover, MA 02339 USA" is written in gray below the company name. T 781.826.9190 F 781.826.4465 denalicorporation.com | June 22, 2014<br>ADDRESS | DENALI CORPORATION<br>134 Old Washington Street / Hanover, MA 02339-1629 | |------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | OWNER/CONTACT PERSON | Dr. Jan G. Stannard | | | TEL: 781-826-9190 / FAX: 781-826-4465 | | | j.stannard@denalicorporation.com | | TRADE NAME | Denali 501 Cement | | COMMON NAME | Resin Cement | | CLASSIFICATION NAME | DENTAL CEMENT (21 CFR 872.3275, Product Code EMA) | | REGISTRATION | 3006367836 | | PREDICATE DEVICES | Cercom II Cement/Denali Corporation (K132393), Variolink Cement/Ivoclar (K971372),<br>Tempbond with Triclosan Cement/Kerr (K053565). | | EQUIVALENCE | The predicate products have been found substantially equivalent<br>under the 510(k) premarket notification process as Class II Dental<br>Devices under CFR EMA 872.3275, Dental Cement. | | DEVICE DESCRIPTION | Denali 501 Cement is a two part, resin-based cement recommended for<br>the bonding of ceramic, metal and composite restorations. Denali 501 contains poly-<br>merizable monomers that can set in either a light activated mode or set upon mixing<br>Part A and Part B. When set the resin has a low solubility in water to act as a long term<br>cement. | | INTENDED USE | Denali 501 Cement is a resin-based cement recommended for<br>the bonding of ceramic, metal and composite restorations.<br>For Use only by a Licensed Dentist. Rx Use Only. | | TECHNOLOGICAL<br>CHARACTERISTICS<br>SUMMARY | Denali 501 Cement has the same technological characteristics<br>as the predicate devices Temp Bond and Variolink including: design,<br>composition, biocompatibility, performance, ageing, intended use, safety and<br>effectiveness, physical characteristics, setting, solubility, film thickness, depth of cure<br>and mechanical properties (tensile and compressive strength). | | BIOCOMPATIBILITY | Denali 501 Cement was found to be biocompatible, and is consistent in formulation<br>to Tempbond and Variolink, in its intended use, biocompatibility, and properties<br>compared to Tempbond and Variolink. | | SUBSTANTIAL<br>EQUIVALENCE<br>DETERMINATION AND<br>SUMMARY | Denali 501 Cement is substantially equivalent in design,<br>composition, biocompatibility, performance, ageing, intended use, and safety and<br>effectiveness to Tempbond and Variolink. This assessment is based upon<br>a comparison of the physical and mechanical characteristics (tensile strength, com<br>pressive strength), solubility, film thickness, depth of cure, and setting time.<br>The results of these tests are consistent with values of Tempbond and Variolink. | | CONCLUSIONS | Denali 501 Cement has been found to be substantially equivalent<br>in design, composition, ageing, biocompatibility, performance, intended use, and<br>safety and effectiveness to Tempbond and Variolink. |
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...